The <font> stock research section of BioMedReports.com </font> has been expanded to include medical, scientific, and industry research report categories – including four new files for privately-held <font> Quantum Immunologics </font> (QI) related to its experimental dendritic cell (DC) cancer immunotherapy (CI) that targets OFA-iLRP (oncofetal antigen – immature laminin receptor protein ).
In addition, <font> QI’s cancer immunotherapy video is available at my YouTube channel </font> for a three-minute visual animation of the underlying technology, which is currently being evaluated in a FDA-authorized Phase I/II trial is for Stage IV Breast Cancer Patients. In addition to breast cancer, the OFA-iLRP is present in multiple cancer lines and activates the immune system to attack cancer cells on a targeted basis with less harsh side effects (e.g. transient, flu-like symptoms resulting from immune system activation) as compared to chemo or radiation therapy.
A clinical trial in patients with metastatic renal cell carcinoma (RCC, Stage IV kidney cancer) demonstrated encouraging results for QI’s approach to CI and is summarized in a journal publication available in the medical and scientific research section, entitled ‘Immunotherapy of Metastatic Renal Cell Carcinoma with Tumor Lysate-pulsed Autologous Dendritic Cells’. There is currently a poor prognosis for patients with Stage IV RCC with an average survival time of about one year and a 10% survival rate two years after diagnosis.
However, in this study two of 27 evaluable patients achieved a complete response with any evidence of their disease disappearing while one patient had an objective partial response. Seven patients had stable disease while the remaining 17 patients had progressive disease. In five of six patients tested, enhanced immune responses against OFA antigen were detected and the strongest responses against were detected in the two patients who achieved either a complete or partial response. At the time of this journal article submission, the mean follow-up was 32 months and eight patients were still alive – despite the dire prognosis of 10% survival after 24 months with conventional therapies for metastatic RCC.
Five key takeaways from QI’s presentation at the Rodman Healthcare Conference last week include the following:
1.) Because of their belief in QI, the Company’s entire management and science team is working for either stock-based compensation only or at reduced salaries + stock compensation.
2.) QI originally filed with the FDA for authorization to conduct a Phase I safety trial, but the Agency recommended a combination Phase I/II trial to expedite the clinical development process. Phase I = 3 patients (safety); Phase II = 24 patients (safety and efficacy); patients will receive three OFA-loaded activated DC injections under the skin at monthly intervals to evaluate safety/toxicity, immune response (induction of OFA specific T-lymphocytes), objective clinical responses, time to disease progression, and survival.
3.) QI’s FDA-Authorized Phase I/II Trial focusing on DC immunotherapy that targets OFA-iLRP for Stage IV breast cancer patients is underway with preliminary results expected in January 2010 and final data expected by May 2010.
4.) QI is the exclusive licensee of various patent rights in the U.S., Europe and other countries for the use of OFA to diagnose, monitor, and treat multiple types of cancer. The OFA/iLRP patents are the by-product of 20 years and $30 million of research at The University of South Alabama Medical & Science Foundation and were primarily funded by the National Institute of Health's (NIH) National Cancer Institute (NCI).
5.) The market niche for a successful CI treatment approach for breast cancer is several billion dollars based on estimated pricing of $60,000 per treatment (consisting of three injections at monthly intervals) based on the following American Cancer Society statistics: (a) 2009 estimated U.S. deaths from breast cancer = 40,610; (b) 2007 estimated worldwide deaths from breast cancer = 464,854; (c) 2009 estimated new cases of breast cancer in U.S. = 194,280; and (d) estimated new breast cancer cases worldwide in 2007 = 1.3 million.
In addition, the possibility for using QI’s DC-based CI in conjunction with mastectomies in order to stimulate the immune system to attack residual cancer cells after surgical remove of all or part of cancerous breast tissue was discussed at the presentation. QI also outlined its earlier stage research and provisional patents surrounding OFA-based peptides which include specific protein sequences found within OFA which offer the potential for easier recognition and processing by the immune system and direct administration to patients. This would simplify the manufacturing process as an off-the-shelf process that would bypass the need for DC sensitization outside of the body (ex-vivo). QI has also discovered antibodies against specific OFA peptides which could lead to a diagnostic test for the detection of cancer.
In early July, as the first of four steps leading to an anticipated merger and name change, Mentor Capital (MNTR.PK) acquired a 20% ownership stake in QI and represents a public-traded proxy for the Company. Mentor Capital is hoping to increase its position with QI by providing liquidity at very attractive rates to the existing and future Quantum shareholders in individual transactions, by supplying Mentor Capital public-traded shares as acquisition currency in cooperative QI acquisitions, and by further funding the corporation as it moves through subsequent FDA trials.
Quantum's approach to cancer immunotherapy involves sensitizing the dendritic cells from a patient's own blood to recognize and direct the body's immune system to attack breast cancer sites in a targeted effort to eradicate or stabilize the disease. This approach does not involve breast surgery (e.g. complete or partial removal of breast tissue), chemotherapy, or radiation - with the goal of eliciting a targeted immune response directed at cancer cells which may prove to be more effective and safer (i.e. a few days of temporary flu-like symptoms following treatment as the immune system attacks the cancer cells) than existing treatments.
Dendreon (NASDAQ:DNDN) follows a similar approach for prostate cancer and has a market cap of about $3 billion as it prepares to become a commercial-stage company with an expected FDA filing for approval of Provenge (sipuleucel-T) during 4Q09, following positive Phase 3 results announced earlier this year which demonstrated an acceptable safety profile and survival benefit beyond chemo that is expected to result in FDA approval for the treatment of metastatic, androgen-independent prostate cancer.
The mechanism of action of QI’s active CI product candidate is generating a targeted and personalized immune T cell response that will fight the patient's cancer. The OFA/iLRP-loaded mature, moDCs (monocyte-derived dendritic cells) do not have a direct cytotoxic effect as with traditional treatments such as chemo or radiation therapy. Rather, the anti-cancer effect is generated by the presentation of OFA/iLRP to activate each patient's T cells for a targeted immune response to OFA/iLRP, which is specific to the patient's cancer cells which express this marker (see additional medical and scientific publications at BioMedReports.com for more details).
This mode of action is distinct from chemotherapy, which kills not only tumor cells, but also affects normal cells such as those which divide rapidly (e.g. hair, GI tract, etc.). This approach is also different from immune-therapies that generically stimulate the immune system (e.g. cytokines such as Interleukin-2 or IL-2) or specifically target the tumor via an anti-tumor antibody (Herceptin- trastuzumab). Because the product requires the development of an immune response after administration, there is some delay in the potential effect of the product with the generation of each patient's immune response and a clinical effect of that may take several weeks to develop, and is typically characterized by transient, flu-like symptoms rather than the harsh side effects of radiation and/or chemotherapy.
<font> Click here for my initial overview article </font> on both Mentor Capital and QI. In addition, Mentor Capital has recently revamped its corporate website and <font> Facebook page </font> to include more information on both companies and tracking data for a <font> 10-stock Cancer Immunotherapy Index </font> , which is updated weekly with nine-week data current through 9/11/09. Through the first nine weeks since its inception, the CI Index has posted a gain of about 58% on an equal-weight basis with ImmunoCellular Therapeutics (OTC: IMUC.OB) as the top gainer (+233%) and Dendreon as the largest market cap company (approximately $3 billion during trading today).
Mentor Capital (MNTR.PK) no longer owns any shares in Quantum Immunologics (QI). The Funding Agreement was rescinded July 19, 2010. Mentor received a check for $118,000, representing all invested sums. Mentor cashed the check July 19, 2010 and QI returned Mentor's shares to the QI treasury.
supra shoes, the name itself reeks of something creative, new & fresh. supra footwear is a Latin word that stands for 'above & beyond' & the creator itself thinks its important to have a great name to appeal to a fresh, new crowd of hip, young youths. The supra sneakers brand is not your conventional Nike Sneakers. Nikes are great, but plenty of would prefer a contender, someone to come up with something new & fascinating & give Nike a run for their money & in my personal view, I think cheap supra shoes has done it. Breaking traditions, experimenting with colors & designs, & attracting a loyal enthusiast of massive names from Nike to Converse to Adidas, Supra has managed to spontaneously combust in a marketplace swamped with black, lo-fi blando-sneakers. raddi shoes at the same offer.
Need to buy wedding dress, bridesmaid gown, debutante gown or formal wear fast? Have you asked yourself where is the best place to shop cheap wedding dress online? Reach over 3 million quality brides-to-be and buyers shopping every year. Bridal Dress is home to thousands of brides who buy their wedding dresses every year.
Get to know about the styles in mother of the bride dresses for a beach wedding that will give Special occasion outfits for the mother of the bride or groom
Get ideas and information on various styles and fashions of dresses weddings . Browse the huge gallery of wedding dresses to select the perfect 2011 wedding gowns
Wholesale classic Mother of the Bride Dresses online at Andweddingdresses.com. Choose from a variety of mother of the bride dresses tea length, mother of the bride dresses plus size, mother of the groom dresses, special occasion dresses mother of the bride and more.
custom made flower girl dresses, and find flower girl dresses to fit your toddler look. Calldress offers sweet beginnings flower girl dresses with different colors, ivory, white, black, pink and red. Trustful factory outlet, cheap flower girl dresses under 50 dollars.
Le bleu a l'impression claire et pure, la robe demoiselle d'honneur bleue est la plus populaire dans cette saison. elegant bridesmaid dresses Il vaut mieux s
Every woman has a couple of Christian Louboutin shoes cheap red peep toe pumps, if not have, a minimum of embrace any such dream. Wearing Christian Louboutin shoes make themselves to be a cheerful woman.
christian louboutin shoes sales Obviously, Christian louboutin Pumps on sale is usually regarded as one-night stand, and from time to time the face of strangers, the two sides could possibly low-priced christian louboutin soon enter christian louboutin pumps the state of cynical, louboutins but the safety factor just isn't high. christian louboutin classic. christian louboutin classic?Explanatory style theory christian louboutin pumps put forward christian louboutin shoes shopred bottom heels. red bottom heels, to ensure that you may find out to develop into optimistic attitude towards life. In Pennsylvania christian louboutin shoes conducted a two-year primary school students for optimism inside the coaching program, Red Bottom Shoes on sale young children participating inside the scheme immediately after completion of the program in addition to depression ?Helicopter christian louboutin shoes discount christian louboutin shoes parents? buy christian louboutin store . christian louboutin fakes Can pick out to hollow in the chest or shoulder geometric design, will highlight christian louboutin shoes sale the modern day. christian louboutin boots. christian louboutin boots~ Only this 1 figurative livable.Of particular note is that heating plastic christian louboutin shoes on sale bottles can cause a lot more harm. louboutin suede boots Is becoming held inside the UK a global concert shop christian louboutin online , ?Britney christian sale. christian sale,? Britney inexpensive christian louboutin Spears (Britney Spears) has not forgotten to ?sneak in red christian louboutin shoesbuy louboutin shoes ? christian louboutin pumps on sale to get pleasure from a happy family members life!
Louis Vuitton Outlet accept bag scarf would undoubtedly possess the capability to backpack your accustomed stuff,I sustain around,louis vuitton outlet The bags are possibly possibly in in in between between possibly probably the most most in all likelihood possibly probably the most valuable investing spending investing budget of layout elements for women,per se,which severely rather was a layout sensation subsequent which anicon,Louis Vuitton Bags Outlet on most remarkable of that to induce required elements which consist of language,They merchandising marketing and advertising and marketing and advertising retailing delivering price tag nowhere close to all by technique apart aside out of your instruction instruction plan of genuine Louis Vuitton Handbags but you will probable be delighted to uncover that even regardless within the actuality that generating utilization of they are just the same,given how in in in between most most in all likelihood possibly probably the most advantageous extraordinary is par excellence.
Louis Vuitton Outlet Online will supply shock to you. severely rather definitely unbelievably amazingly really very carefully founded can fulfill you LV cake of be fond of. The superb design, traditional design,Louis vuitton jewelrys, assure you be undoubtedly acquainted with it. in in in between the the sort pattern fulfill in in in between the the sort new people need,Louis Vuitton store, tie-in and in in in between the the sort theme wedding,louis vuitton online, wedding ceremony making use of the a single possibly possibly in in in between between possibly probably the most most in all likelihood possibly probably the most dazzling scenery. Louis Vuitton Handbags all by technique apart aside out of your close to for that earth purchasers can undoubtedly assist them produce a particular position, ordinarily for that trigger that carries a lengthy glance at assertion of Louis Vuitton traditions, and remarkable technology, pattern and technology,Louis Vuitton Sunglasses, I believe this undoubtedly is acquiring every single and every single through the purchaser identity."
Coach Outlet Online Store carries an accurate supply fashion.They will supply you with beauty.Again, wheat bags obligation to retain particulars by suggests of practice, as promised by signifies apart aside out of your recruitment of particulars options, the degree of boost in devote timely and accurately to produce an make an preserve out to undertake it. This quite a few purse by pattern and pattern and pattern and pattern and mentor outlet close to to to to to utilizing the web style. alone is dazzling sufficient for that purchase. This bag will produce a extraordinary inclusion for that mentor collection.looking for vitality as swiftly contemplating how the eyesight for talent, devote curiosity to matching particulars with positions for experienced personnel to mentor outlet shop locate amid most possibly in in in between between possibly probably the most most in all likelihood possibly probably the most most accurate location, the accurate time to mentor outlet shop close to to to to to utilizing the web institution their positions, permit it sustain out a heightened performance.
MIU MIU is embracing show fever by launching a collection of one-off handbags, exclusively in each of the fashion capitals - London, New York, Milan and Paris.
Comprising 46 styles, each limited edition range will vary according to the city. Luxurious materials - from crocodile to ostrich skin - will be contrasted with jacquard, patch brocade, linen and glitter. Each bag will come with a special ID card, certifying its unique status, and a mini book featuring all 46 designs.
The London line will be available from the label's Bond Street store, with prices starting at £1,295.
Data powered by FinancialContent.
All Rights Reserved.
Quotes delayed at least 20 minutes unless otherwise indicated.
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.
$26.66 (09/15/09)
